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A novel in vivo model to study bacterial pathogenesis and screen
potential therapeutic targets
Escherichia coli sepsis and meningitis are
among the leading causes of neonatal
bacterial infections, affecting from 0.5 to 5
per 10 000 live births in developed countries,
with far greater numbers in developing
countries. E. coli K-1 meningitis alone
contributes to .50 000 deaths per year
worldwide (Gladstone et al., 1990; de Louvois
et al., 1991; Kim, 2003; Alarcon et al., 2004;
Bonacorsi & Bingen, 2005). As E. coli K-1
meningitis is limitedmostly to neonates, who
depend largely on an innate immune
response to counter infection, we previously
hypothesized that insects are useful models to
study the pathogenesis of E. coli K-1. For the
first time, we demonstrated that locusts can
be used as a model to study E. coli K-1
pathogenesis (Khan & Goldsworthy, 2007;
Mokri-Moayyed et al., 2008). The significant
findings included the fact that E. coli K-1
invades the locust central nervous system and
kills locusts. Furthermore, E. coli K-1
pathogenesis within both locust and
vertebrate systems was shown to be
dependent upon several common established
virulence factors (Khan & Goldsworthy,
2007;Mokri-Moayyed et al., 2008). Such data
support the use of a locust system to
successfully model E. coli infection and study
its pathogenesis. In the present study, it was
determined further whether locusts can be
used as an in vivo model to study bacterial
pathogenesis and to screen potential vaccine
targets against E. coli K-1 infection.
African migratory locusts, Locusta
migratoria, between 15 and 30 days old with
a fully developed innate immune system
were used in the present study (Goldsworthy
et al., 2003). They were fed on bran, wheat
seedlings and fresh grass and live an average
of 80–100 days. E. coli K-1 strain RS218
(O18 :K-1 :H7) is a spontaneous rifampicin-
resistant mutant derived from the
cerebrospinal fluid of a neonate with
meningitis (Khan & Goldsworthy, 2007;
Achtman et al., 1983). In addition,
Staphylococcus aureus (clinical isolate
obtained from blood cultures provided by S.
Alsam, Luton & Dunstable Hospitals, UK)
was used. The sensitivity patterns of S. aureus
demonstrated its susceptibility to gentamicin
and resistance to penicillin, in vitro. In
addition, a laboratory strain of E. coli K-12
strain HB101 was used as a non-invasive
isolate. All bacterial isolates were grown at
37 uC in Luria–Bertani broth. A clinical
isolate of Acanthamoeba castellanii of the T4
genotype was used (ATCC 50492) by
growing without shaking in 10 ml PYG
culture medium [0.75% (w/v) proteose
peptone, 0.75% (w/v) yeast extract and
1.5% (w/v) glucose] in T-75 tissue culture
flasks at 30 uC as described previously (Khan
& Siddiqui, 2009). The medium was
refreshed 24 h prior to experiments, which
resulted in more than 95% amoebae in the
infective trophozoite stage.
For all assays, locusts were allocated
randomly into groups of ten, except where
indicated otherwise, and experiments were
repeated at least three times. For mortality
assays, each experimental locust was
injected with 20 ml culture medium
containing 26106 bacterial c.f.u. into the
haemocoel of the locust abdomen by
inserting the needle into the
intersegmental membrane between two
abdominal terga as previously described,
and mortality was recorded every 24 h. In
the control group, locusts were injected
with culture medium alone.
In some experiments, locusts were injected
with a variable number of heat-killed
bacteria or A. castellanii (heat-kill was
achieved by incubating at 65 uC for 30 min
and confirmed by culturing). For simplicity,
this is described as ‘immunization’,
although in general invertebrates are not
known to possess an acquired immune
system. So-called ‘immunized’ locusts were
kept for 24 h at 30 uC. Following this
incubation, locusts were challenged with live
invasive E. coli K-1 (26106 c.f.u.) and
mortality was recorded every 24 h. The
control group was injected with culture
medium alone at both time intervals. For
some experiments, locusts were divided into
seven groups and injected with heat-killed
bacteria (106 c.f.u.). Next, each group was
challenged with live invasive E. coli K-1
(26106 c.f.u.) every 24 h up to 7 days and
mortality was recorded.
Heat-killed non-invasive
E. coli K-12 can protect
locusts against subsequent
challenge of invasive K-1
Consistent with previous findings, locusts
injected with E. coli K-1 alone (26106
c.f.u.) showed 100% mortality within 72 h,
while K-12 showed zero mortality. To
determine whether ‘immunization’ with
heat-killed K-1 (106 c.f.u.) or K-12 (106
c.f.u.) can protect locusts against sub-
sequent challenge with live K-1 (26106
c.f.u.), assays were performed as described
above. It was surprising to note that locusts
immunized with either heat-killed K-1 or
heat-killed K-12 showed zeromortality with
subsequent injection of live K-1 within
72 h. Experiments were repeated three
times with reproducible results. The control
group of locusts that were injected with
culture medium alone showed 0% mortal-
ity in 72 h. Similarly, locusts injected with
heat-killed bacteria without subsequent
challenge with live K-1 showed zero mor-
tality, indicating no adverse effects due
to so-called ‘immunization’. The results
revealed that prior injection with heat-
killed E. coli K-12 can indeed protect locusts
against the consequent challenge of infec-
tion with K-1. The use of non-invasive E.
coli K-12, safely, to protect a host against an
invasive strain was unexpected. A PubMed
literature search revealed no evidence of any
such studies carried out in vertebrates and
warrants further investigations.
Use of different inoculum of
heat-killed E. coli K-12 to
‘immunize’ locusts
To determine the effects of the inoculum
size on immunization, locusts were injected
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with 103–106 c.f.u. of heat-killed E. coli K-
12, left for 24 h and then injected with live
K-1 (26106 c.f.u.). One hundred per cent
locust mortality occurred in groups that
were immunized with 103 c.f.u. of heat-
killed K-12 in 72 h. In locusts immunized
with 105 c.f.u. of K-12, 16.6%±2.2 mor-
tality was observed within 72 h. However,
in the group of locusts injected with 104
c.f.u. of heat-killed E. coli K-12, 83%±7.4
mortality was observed, revealing that
inoculum size has an effect on the immun-
ization of the locusts. In contrast, locusts
injected with 56105 and 106 c.f.u. of heat-
killed E. coli K-12 alone showed 0%
mortality within 72 h. Again, there was no
mortality in the control group (culture
medium-injected locusts). In the locusts
group injected with live K-1 (26106 c.f.u.)
alone, 100% mortality was observed within
72 h with more than 50%±6.1 mortality
occurring within 48 h.
Use of various microbes to
induce immunity against
E. coli K-1
Several lines of evidence suggest that insects
possess and/or induce antimicrobial pep-
tides in response to microbial infection
(Steiner et al., 1988; Hoffmann & Hoffmann,
1990; Cociancich et al., 1994; Otvos,
2000; Andra¨ et al., 2001). To determine
immune specificity, locusts were injected
with heat-killed K-12 (106 c.f.u.), heat-
killed S. aureus (106 c.f.u.) and heat-
killed Acanthamoeba species (106) and
left for 24 h. Following this, locusts were
challenged with live K-1 (26106 c.f.u.)
and mortality was recorded every 24 h.
The results revealed no mortality in
locusts immunized with heat-killed E.
coli K-12 within 72 h. However, locusts
injected with heat-killed S. aureus or
Acanthamoeba species showed .90%
mortality within 72 h, suggesting immune
specificity.
E. coli K-12-induced
immunity lasts up to 5 days
Insects are known to rely on innate im-
mune system to counter infections (Steiner
et al., 1988; Hoffmann & Hoffmann, 1990;
Cociancich et al., 1994; Otvos, 2000; Andra¨
et al., 2001). To establish how long E. coli K-
12-induced immunity persists, locusts were
divided into seven groups and injected with
heat-killed bacteria (106 c.f.u.). Next, each
group was challenged with live E. coli K-1
(26106 c.f.u.) every 24 h up to 7 days and
mortality was recorded. It was observed that
locusts immunized with K-12, kept for 24 h
and then challenged with live K-1 (26106
c.f.u.) showed zero mortality within 72 h.
Locusts injected with K-12, kept for 48 h
and then challenged with live K-1 showed
zero mortality and similar results were
observed for up to 5 days. However, locusts
injected with K-12, kept for 6 days and then
challenged with live K-1 showed 80%±5.4
mortality, while locusts immunized for 7
days recorded 100% mortality. Our find-
ings that K-12-induced immunity in locusts
against invasive K-1 persists for up to
5 days are novel. Notably, recent studies
have shown that cells of the innate immune
system are capable of ‘memory’, and of
mounting rapid protection, challenging
previous thought that only B cells and T
cells can store memory to ward off
subsequent infection (Gillard et al., 2011).
Although the notion of ‘specific memory’ in
invertebrates is a fascinating area that
warrants further investigation, the under-
lying mechanisms remain unknown. It is
suggested that induction of non-specific
mechanisms on their own may lead to more
specific memory when expressed in com-
bination (Kurtz, 2005). Examples include
Toll, immune deficiency (Imd), peptido-
glycan recognition molecules and lectins,
and fibrinogen-related proteins that consist
of one or two Ig superfamily domains,
which could be expressed stably in the host
after the primary exposure (reviewed by
Kurtz, 2005) and may explain the findings
observed in the present study. Future
studies will identify the complementary or
alternative mechanisms in the invertebrate
immune system that give rise to specific
memory.
Usefulness of locusts as a
model to screen potential
therapeutic agents
At present, the recommended antibiotic
against E. coli K-1 meningitis in clinical
settings is gentamicin. To demonstrate the
potency of gentamicin in our model
system, locusts were injected with K-1 as
described above, followed by injection of
gentamicin (25 mg to achieve 100 mg ml21;
as the total haemolymph in locusts is
normally 250 ml) 60 min post-infection.
For negative antimicrobial control groups,
rifampicin-resistant K-1-infected locusts
were injected with rifampicin at the above
concentrations. The administration of anti-
biotics was continued, once a day, for up to
5 days. It was observed that gentamicin
protected locusts against K-1-mediated
death, i.e. mortality recorded at 7%±4
after 5 days. For controls, K-1-infected
locusts injected with rifampicin showed
100% mortality, while locusts injected with
antibiotics alone showed mortality at levels
similar to those injected with K-12.
In an attempt to determine the usefulness of
the locust model to investigate antimicro-
bial chemotherapy against Gram-positive
bacteria, S. aureus was used. The sensitivity
patterns of S. aureus demonstrated its
susceptibility to gentamicin and resistance
to penicillin in vitro, hence penicillin was
used as a negative antimicrobial control.
Locusts injected with 20 ml of a suspension
(26106 c.f.u.) of S. aureus showed
72.5%±5 mortality. To demonstrate the
potency of gentamicin, locusts were injected
with S. aureus, followed by injection of the
antibiotic as described above. For controls,
bacteria-infected locusts were injected with
penicillin (25 mg to achieve 100 mg ml21).
Interestingly, gentamicin showed potent
effects in protecting locusts against S.
aureus-mediated mortality at aforemen-
tioned concentrations, i.e. zero mortality
recorded after 5 days. The negative anti-
microbial control group showed mortality
at levels similar to S. aureus-infected
groups, i.e. 65%±4 mortality. Overall,
these findings suggest the usefulness of
locusts as an in vivo model to screen
potential therapeutic agents.
In conclusion, these studies suggested that
immunization at a high inoculum with
non-invasive E. coli K-12 can protect locusts
against invasive K-1, and the locust
immune system is capable of memory and
mounting protection against subsequent
infection for up to 5 days. Additionally,
the usefulness of locusts as a novel in vivo
model to screen large chemical (natural or
synthetic) libraries is highlighted. Future
studies will determine bacterial antigenic
determinants and how the innate memory
functions in locusts. A complete under-
standing of how locusts’ innate immune
cells (i.e. haemocytes) respond robustly and
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specifically against bacterial pathogens will
be crucial for developing effective vaccines
and/or exerting early control of neonatal E.
coli infection.
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